|
Restoration of proteostasis to address co-occurring conditions in Down Syndrome |
1RF1AG078969-01 |
|
NIA |
2022 |
|
Cell and Network Disruptions and Associated Pathogenenesis in Tauopathy and Down Syndrome |
3R01AG064579-03S1 |
|
NIA |
2022 |
|
Treating with Gamma-Secretase Modulators to Prevent Neurodegeneration in Mouse Models of Down Syndrome and Alzheimer Disease |
5R01AG055523-05 |
|
NIA |
2022 |
|
Cell and Network Disruptions and Associated Pathogenenesis in Tauopathy and Down Syndrome |
5R01AG064579-03 |
|
NIA |
2022 |
|
Acute Prenatal Alcohol Exposure Potentiates Conotruncal Defects in the Setting of a Permissive Genetic Background |
1F30AA029936-01A1 |
|
NIAAA |
2022 |
|
Simultaneous prenatal alcohol and cannabinoid exposure & offspring corticostriatal neurocircuitry |
1F32AA029866-01A1 |
|
NIAAA |
2022 |
|
Consequences of combined prenatal alcohol exposure and acute placental ischemia on frontal cortical-sensitive behavior, structure, and physiology in juvenile offspring |
1K08AA030080-01 |
|
NIAAA |
2022 |
|
Mechanisms for predisposition to AUD following prenatal alcohol and THC comorbidity |
1K99AA029167-01A1 |
|
NIAAA |
2022 |
|
Role of Microglia in Prenatal ethanol exposure-induced Impairment of Endocannabinoid Signaling |
1R01AA028476-01A1 |
|
NIAAA |
2022 |
|
Fetal cerebral arteries and prenatal alcohol exposure |
1R01AA029673-01 |
|
NIAAA |
2022 |